NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Exo Lab Italia

Exo Lab Italia

Private
L'AquilaHealthcare & Life Scienceshttps://www.exolabitalia.net/

Last Round

Series A

Feb 18, 2025

Total Funding Raised

$6.26M

Company Overview

Exo Lab Italia is a biotechnology company that creates innovative products based on plant exosomes from organic farming for dermocosmetic, nutraceutical, and life science applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Advanced Materials, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

plant-derived exosomesexosome technologycosmetic ingredientsnutraceutical ingredientsbotanical exosomesskincare ingredientsB2B ingredientsactive ingredientsR&D servicesclean beauty ingredientscustom formulationsustainable ingredientscosmeceuticalsnanovesiclesbioavailability

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Exo Lab Italia Comparables

Compare Exo Lab Italia with similar companies based on industry and business-model similarity.

Exo Lab Italia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Active Botanicals Research srl
81%
Solabia Group
78%
LipoTrue
77%

Exo Lab Italia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 18, 2025
AcceleratorOct 1, 2022
SeedDec 23, 2021

Key People

Founding team and executive leadership

Lorenzo Cilli

Founder & CFO

Founding Team

Mariantonia Logozzi

CTO, Head Of R&D, Founder Exolab Italia

Founding Team

Salvatore-Valerio Ferri

Chief Executive Officer

Executive Team

Exo Lab Italia Investors

Notable investors and investment history

Exo Lab Italia investors
InvestorRounds
Terra Next AcceleratorAccelerator
Maia VenturesSeries A
CDP Venture Capital SGRSeries A
Scientifica Venture CapitalSeries A, Accelerator, Seed
Riello Investimenti SGRSeries A
DSM-Firmenich VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 22, 2026

    Grew 31% QoQ from 13 to 17 employees.

Exo Lab Italia Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Exo Lab Italia Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Exo Lab Italia's valuation, stock price, and market status.

Firmographic Details

HeadquartersL'Aquila
Employee Range21
Year Founded2020
Last FundingFeb 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.